FDA.reportPublic FDA data

PANCRELIPASE PROTEASE

Substance profile for UNII 3560D81V50, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
3560D81V50
Preferred term
PANCRELIPASE PROTEASE
Registry number
9001-94-9
Ingredient type
INGREDIENT SUBSTANCE

Chemical And Database Identifiers#

RxCUI
1427034
PubChem
0
NCIt
C84041
INN ID
0
ITIS
180722
NCBI
9823

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1427034mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1427034
NCI ThesaurusC84041ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84041
FDA Substance Registration System3560D81V50precision.fda.gov/uniisearch/srs/unii/3560D81V50

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTThese highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP ® (pancrelipase) delayed release capsules Initial U.S. Approval: 20091
ACTIVE MOIETYThese highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP ® (pancrelipase) delayed release capsules Initial U.S. Approval: 20091
ACTIVE MOIETYDrug Facts1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20095
ACTIVE MOIETYThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20095
ACTIVE MOIETYThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
ACTIVE INGREDIENTThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
ACTIVE INGREDIENTThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
ACTIVE MOIETYThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
ACTIVE INGREDIENTThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
ACTIVE MOIETYThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
ACTIVE INGREDIENTCREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE [ABBVIE INC.]57
ACTIVE MOIETYCREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE [ABBVIE INC.]57
ACTIVE MOIETYZENPEP (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC.]17
ACTIVE INGREDIENTZENPEP (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC.]17
ACTIVE INGREDIENTPANCRELIPASE CAPSULE, DELAYED RELEASE [X-GEN PHARMACEUTICALS, INC.]14
ACTIVE MOIETYPANCRELIPASE CAPSULE, DELAYED RELEASE [X-GEN PHARMACEUTICALS, INC.]14
ACTIVE MOIETYPERTZYE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [DIGESTIVE CARE, INC.]12
ACTIVE INGREDIENTPERTZYE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [DIGESTIVE CARE, INC.]12
ACTIVE INGREDIENTPANCREAZE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [JANSSEN PHARMACEUTICALS, INC.]5
ACTIVE MOIETYPANCREAZE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [JANSSEN PHARMACEUTICALS, INC.]5
ACTIVE INGREDIENTULTRESA (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC]4
ACTIVE MOIETYULTRESA (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC]4
ACTIVE INGREDIENTPANAKARE PLUS (PANCREATIC ENZYME) TABLET [NEOGEN CORPORATION-MERCER]3
ACTIVE MOIETYPANAKARE PLUS (PANCREATIC ENZYME) TABLET [NEOGEN CORPORATION-MERCER]3
ACTIVE MOIETYVIOKACE (PANCRELIPASE) TABLET [APTALIS PHARMA US, INC]3
ACTIVE INGREDIENTVIOKACE (PANCRELIPASE) TABLET [APTALIS PHARMA US, INC]3
ACTIVE INGREDIENTPANAKARE PLUS (PANCREATIC ENZYME ) POWDER [NEOGEN CORPORATION-MERCER]2
ACTIVE MOIETYPANAKARE PLUS (PANCREATIC ENZYME ) POWDER [NEOGEN CORPORATION-MERCER]2
ACTIVE INGREDIENTPANCRELIPASE CAPSULE, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS]2
ACTIVE MOIETYPANCREAPOWDER PLUS (PANCREATIC ENZYME CONCENTRATE PLUS FAT SOLUBLE VITAMINS) POWDER [HENRY SCHEIN ANIMAL HEALTH]1
ACTIVE INGREDIENTPANCREAPOWDER PLUS (PANCREATIC ENZYME CONCENTRATE PLUS FAT SOLUBLE VITAMINS) POWDER [HENRY SCHEIN ANIMAL HEALTH]1
ACTIVE MOIETYPANCREPLUS (PANCREATIC ENZYME) TABLET [MWI/VETONE]1
ACTIVE INGREDIENTPANCREPLUS (PANCREATIC ENZYME) TABLET [MWI/VETONE]1
ACTIVE MOIETYPANCREVED (PANCREATIC ENZYME) TABLET [VEDCO, INC]1
ACTIVE INGREDIENTPANCREVED (PANCREATIC ENZYME) TABLET [VEDCO, INC]1
ACTIVE INGREDIENTPANCREZYME POWDER [VIRBAC AH, INC.]1
ACTIVE MOIETYPANCREZYME POWDER [VIRBAC AH, INC.]1
ACTIVE MOIETYPANCREZYME TABLET [VIRBAC AH, INC.]1
ACTIVE INGREDIENTPANCREZYME TABLET [VIRBAC AH, INC.]1